News Highlights: Top Company News of the Day
AstraZeneca Defends Dosing Error in Covid-19 Vaccine Trial
A top AstraZeneca executive pushes back against criticism that
the company failed to disclose enough data from a clinical trial of
its Covid-19 vaccine.
Facebook's Latest Error Shakes Advertisers' Confidence
The company quietly told advertisers this month that its
"conversion lift" tool, used to measure outcomes, overestimated
some campaign results.
TikTok Granted Extension on Divestiture Order
Federal officials have granted TikTok and its Chinese parent
ByteDance a weeklong extension of a deadline for completing a
divestiture deal, in another delay of the Trump administration's
effort to turn the social-media app into an American company.
Salesforce Is in Talks to Acquire Slack Technologies
A deal, which would mark a big move by the corporate-software
maker into office communications, could be reached in days.
Justice Department Clears Intuit to Buy Credit Karma
Antitrust officials cleared Credit Karma's pending $7.1 billion
sale to TurboTax maker Intuit after the two companies agreed to
divest Credit Karma's burgeoning tax-preparation business.
Walmart, Grocers Can Avoid New Mexico Shutdowns With Covid-19 Testing
State officials in New Mexico are offering grocery stores,
retailers and other essential businesses a way to avoid shutdowns
when workers become infected with Covid-19: regularly test all
Amazon Web Services Hit by Outage
The company said it was experiencing errors that were causing
issues for a range of cloud-software programs in its region
covering the eastern part of the U.S.
Delta, Pilots Strike Deal to Save Jobs
Pilots agreed to accept reduced pay in exchange for job security
until 2022, as the industry continues to grapple with reduced
travel demand due to the pandemic.
GE Appliances Turns Up the Speed on Supply-Chain Upgrade
Coronavirus-driven disruptions in demand and production added
urgency to a GE Appliances digital supply-chain upgrade aimed at
building visibility and flexibility.
China Drugmakers Face Pressure to Prove Their Covid-19 Vaccines Work
Pressure is mounting on Chinese drugmakers to show clinical
evidence that their leading Covid-19 vaccines work, after early
data on three Western-developed shots showed promising
effectiveness against the disease.
(END) Dow Jones Newswires
November 25, 2020 23:15 ET (04:15 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.